ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.
Anhui Hongyu Wuzhou Medical Manufacturer Co.,Ltd. engages in the research, development, production, and sale of disposable sterile infusion medical devices in China. It offers disposable syringes, infusion (blood) devices, puncture needles, hypodermic needles, blood collection needles and sets, conventional syringes, and insulin syringes and pen needles, as well as infusion, blood administration,… Read more
ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. (301234) - Net Assets
Latest net assets as of June 2025: CN¥752.64 Million CNY
Based on the latest financial reports, ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. (301234) has net assets worth CN¥752.64 Million CNY as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥853.46 Million) and total liabilities (CN¥100.82 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥752.64 Million |
| % of Total Assets | 88.19% |
| Annual Growth Rate | 40.81% |
| 5-Year Change | 292.27% |
| 10-Year Change | N/A |
| Growth Volatility | 63.99 |
ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. - Net Assets Trend (2019–2024)
This chart illustrates how ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. (2019–2024)
The table below shows the annual net assets of ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥762.50 Million | +1.71% |
| 2023-12-31 | CN¥749.71 Million | +3.63% |
| 2022-12-31 | CN¥723.44 Million | +175.31% |
| 2021-12-31 | CN¥262.77 Million | +35.19% |
| 2020-12-31 | CN¥194.38 Million | +41.23% |
| 2019-12-31 | CN¥137.63 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 376.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥268.43 Million | 35.20% |
| Other Components | CN¥494.06 Million | 64.80% |
| Total Equity | CN¥762.50 Million | 100.00% |
ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. Competitors by Market Cap
The table below lists competitors of ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Yungshin Construction & Development Co Ltd
TWO:5508
|
$108.05 Million |
|
Jaya Tiasa Holdings Bhd
KLSE:4383
|
$108.07 Million |
|
Nippon Coke & Engineering Company Limited
F:NJ2
|
$108.11 Million |
|
Tegma Gestão Logística S.A
SA:TGMA3
|
$108.15 Million |
|
Ngx Energy International Corp
OTCQX:GASXF
|
$108.04 Million |
|
Nafoods Group JSC
VN:NAF
|
$108.03 Million |
|
POLIGHT ASA NK -04
F:3OL0
|
$108.01 Million |
|
Suzhou Mingzhi Technology Co. Ltd. A
SHG:688355
|
$108.01 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 749,707,798 to 762,496,389, a change of 12,788,592 (1.7%).
- Net income of 39,969,810 contributed positively to equity growth.
- Dividend payments of 27,181,219 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥39.97 Million | +5.24% |
| Dividends Paid | CN¥27.18 Million | -3.56% |
| Other Changes | CN¥0.00 | +0.0% |
| Total Change | CN¥- | 1.71% |
Book Value vs Market Value Analysis
This analysis compares ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.46x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 14.37x to 3.46x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | CN¥2.70 | CN¥38.79 | x |
| 2020-12-31 | CN¥3.81 | CN¥38.79 | x |
| 2021-12-31 | CN¥5.15 | CN¥38.79 | x |
| 2022-12-31 | CN¥10.64 | CN¥38.79 | x |
| 2023-12-31 | CN¥11.03 | CN¥38.79 | x |
| 2024-12-31 | CN¥11.21 | CN¥38.79 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.24%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.37%
- • Asset Turnover: 0.55x
- • Equity Multiplier: 1.14x
- Recent ROE (5.24%) is below the historical average (19.46%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 38.44% | 10.86% | 1.52x | 2.32x | CN¥39.14 Million |
| 2020 | 29.19% | 12.04% | 1.44x | 1.68x | CN¥37.31 Million |
| 2021 | 26.03% | 13.33% | 1.34x | 1.46x | CN¥42.12 Million |
| 2022 | 9.80% | 12.96% | 0.65x | 1.17x | CN¥-1.41 Million |
| 2023 | 8.04% | 11.29% | 0.63x | 1.13x | CN¥-14.71 Million |
| 2024 | 5.24% | 8.37% | 0.55x | 1.14x | CN¥-36.28 Million |
Industry Comparison
This section compares ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,879,733,462
- Average return on equity (ROE) among peers: 24.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ANHUI HONGYU WUZHOU Medical Manufacturer Co.LTD. (301234) | CN¥752.64 Million | 38.44% | 0.13x | $108.04 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $792.82 Million | 25.77% | 0.17x | $318.98 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $482.51 Million | 20.84% | 0.32x | $2.79 Billion |
| Double Medical Technology Inc (002901) | $224.61 Million | 43.10% | 0.32x | $404.40 Million |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $1.42 Million | 98.49% | 2.27x | $281.14 Million |
| Lepu Medical Tech Beijing (300003) | $12.27 Billion | 14.01% | 0.69x | $2.71 Billion |
| INKON Life Technology Co Ltd (300143) | $1.81 Billion | -20.17% | 0.37x | $637.77 Million |
| Edan Instruments Inc (300206) | $1.26 Billion | 7.37% | 0.15x | $501.55 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $504.27 Million | 13.31% | 0.36x | $360.97 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $267.10 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $952.60 Million |